NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022Jimmy J. Caudell, Susan Darlow, A. Dimitrios Colevas et al.|Journal of the National Comprehensive Cancer Network|2022Cited by 532
Management of Salivary Gland Malignancy: ASCO GuidelineJ.L. Geiger, Patrick K. Ha, Nofisat Ismaila et al.|Journal of Clinical Oncology|2021Cited by 401
Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO GuidelineEllie Maghami, J.J. Caudell, Nofisat Ismaila et al.|Journal of Clinical Oncology|2020Cited by 221
NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025A. Dimitrios Colevas, Susan Darlow, Anthony J. Cmelak et al.|Journal of the National Comprehensive Cancer Network|2025Cited by 140
American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatmentDavid C. Shonka, Gregory W. Randolph, Alan L. Ho et al.|Head & Neck|2022Cited by 110